Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT05645991
Other study ID # COCOZEN
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date March 8, 2018
Est. completion date January 20, 2022

Study information

Verified date December 2022
Source Ball State University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The goal of this intervention is to determine the efficacy of coconut sap powder (CSP) to lower arterial stiffness and blood pressure in middle-aged and older adults. Participants will be randomized to the CSP arm or Placebo arm of the study. Primary endpoints include: aortic stiffness assessed by carotid-femoral pulse wave velocity, resting brachial and (non-invasive) carotid blood pressure, and carotid stiffness (e.g. Beta stiffness index, Carotid compliance, Elastic modulus, Distensibility).


Recruitment information / eligibility

Status Completed
Enrollment 22
Est. completion date January 20, 2022
Est. primary completion date February 28, 2020
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 40 Years to 80 Years
Eligibility Inclusion Criteria: - Body mass index 18-35 kg/m2 - Brachial blood pressure <140/90 - Nonsmoker - No known clinical disease, or suggestive signs or symptoms of clinical disease - Free of alcohol or drug dependence Exclusion Criteria: - taking any anti-hypertensive, lipid lowering or other cardiovascular altering medications - Known allergies to coconut or tree nuts (i.e., cashews, almonds, or pistachios) - Engaging in vigorous intensity exercise

Study Design


Related Conditions & MeSH terms


Intervention

Dietary Supplement:
Coconut Sap Powder (CSP)
CSP was given once daily (1.5 g/day) for 8 weeks.
Placebo
Capsules containing aspartame (1.5 g/day) were taken orally once daily for 8 weeks.

Locations

Country Name City State
United States Ball State University Muncie Indiana

Sponsors (1)

Lead Sponsor Collaborator
Ball State University

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Change in aortic stiffness Carotid-femoral pulse wave velocity (meters/second) Baseline and 8 weeks
Primary Change in systolic and diastolic brachial blood pressure Manual sphygmomanometer (mmHg) Baseline and 8 weeks
Primary Change in carotid systolic and diastolic blood pressure Applanation tonometry of carotid artery (mmHg) Baseline and 8 weeks
Primary Change in carotid artery stiffness - beta stiffness index Carotid artery Beta stiffness index (AU) Baseline and 8 weeks
Primary Change in carotid artery stiffness - carotid compliance Carotid artery carotid compliance (mmHg/mm^2) Baseline and 8 weeks
Primary Change in carotid artery stiffness - elastic modulus Carotid artery elastic modulus (kilopascals, kPa) Baseline and 8 weeks
Primary Change in carotid artery stiffness - Young's modulus Carotid artery Young's modulus (kilopascals, kPa) Baseline and 8 weeks
Primary Change in carotid artery stiffness - distensibility Carotid artery distensibility (10^-3/kilopascals) Baseline and 8 weeks
Secondary Change in inflammatory biomarker - interleukin 6 Biomarker: Interleukin 6 pg/mL Baseline and 8 weeks
Secondary Change in inflammatory biomarker - interleukin 10 Biomarker: Interleukin 10 pg/mL Baseline and 8 weeks
Secondary Change in inflammatory biomarker - interleukin 1 beta Biomarker: Interleukin 1 beta pg/mL Baseline and 8 weeks
Secondary Change in inflammatory biomarker - tumor necrosis factor alpha Biomarker: Tumor necrosis factor alpha pg/mL Baseline and 8 weeks
Secondary Change in inflammatory biomarker - monocyte chemoattractant protein 1 Biomarker: Monocyte chemoattractant protein 1 pg/mL Baseline and 8 weeks
Secondary Change in inflammatory biomarker - high sensitivity C-reactive protein Biomarker: High sensitivity C-reactive protein mg/mL Baseline and 8 weeks
Secondary Change in oxidative stress biomarkers - superoxide dismutase Biomarker: Superoxide dismutase U/mL Baseline and 8 weeks
Secondary Change in oxidative stress biomarkers - Catalase Biomarker: Catalase U/mL Baseline and 8 weeks
Secondary Change in oxidative stress biomarkers - Oxidized low density lipoprotein Biomarker: Oxidized Low density lipoprotein mU/L Baseline and 8 weeks
See also
  Status Clinical Trial Phase
Completed NCT05433233 - Effects of Lifestyle Walking on Blood Pressure in Older Adults With Hypertension N/A
Recruiting NCT06032065 - Sequential Multiple Assessment Randomized Trial of Exercise for PAD: SMART Exercise for PAD (SMART PAD) Phase 3
Completed NCT05293730 - Trial of the Impact of the Electronic Frailty Integrated With Social Needs N/A
Recruiting NCT03932162 - Gene Expression Changes In Young and Geriatric Skin Early Phase 1
Completed NCT04064528 - Effects of Age on Amino Acid Delivery to Tendon N/A
Completed NCT03366129 - Blood-Brain Barrier Disruption in People With White Matter Hyperintensities Who Have Had a Stroke
Completed NCT06029920 - Influence of Overground Walking on Biomarkers, Cognitive Function, and Quality of Life in Elderly With Mild Cognitive Impairment N/A
Recruiting NCT05543980 - Leg Heat Therapy in Elderly Individuals Phase 2
Recruiting NCT05566938 - Study to Design a Precision Nutrition Strategy at a Group Level in the Elderly N/A
Completed NCT04894929 - Comprehensive Geriatric Assessment in the Monitoring of Functional Improvement N/A
Not yet recruiting NCT06071130 - Emotion, Aging, and Decision Making N/A
Enrolling by invitation NCT04641663 - Multi-target Dietary Supplement Tolerability in an Aging Population (MTDSST) N/A
Completed NCT04088006 - The Evaluation of Efficacy and Safety of Hyaluronic Acid Injection on Skin Moisturization and Elasticity N/A
Completed NCT03695081 - Patient Pathway Pharmacist - Optimal Drug-related Care N/A
Recruiting NCT05424263 - Acetate and Age-associated Arterial Dysfunction Phase 2
Completed NCT05601713 - Mitigating Heat-induced Physiological Strain and Discomfort in Older Adults Via Lower Limb Immersion and Neck Cooling N/A
Completed NCT04551339 - Zinc Versus Multivitamin Micronutrient Supplementation in the Setting of COVID-19 N/A
Recruiting NCT04997577 - Speech Perception and High Cognitive Demand N/A
Completed NCT05922475 - Efficacy of Pre-sleep or Post-exercise Protein During 12 Weeks of Resistance Exercise Training N/A
Completed NCT04015479 - Peanut Protein Supplementation to Augment Muscle Growth and Improve Markers of Muscle Quality and Health in Older Adults N/A